Table 5
Overlap between gene signatures of non-response versus response (current study), short versus long duration of chronic phase with non-imatinib therapy (Yong et al.21 ), and blast crisis versus chronic phase (Zheng et al.16 )
Overlap between gene signatures of non-response versus response (current study), short versus long duration of chronic phase with non-imatinib therapy (Yong et al.21 ), and blast crisis versus chronic phase (Zheng et al.16 )
